2-(2,6-dioxopiperidin-3-yl)-5-((9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)amino)isoindoline-1,3-dione

Catalog No.: 
ACJHIV616
CAS No.: 
-
Molecular Formula: 
C23H21N7O5
Molecular Weight: 
475.46
2-(2,6-dioxopiperidin-3-yl)-5-((9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)amino)isoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$358.00InquiryInquiry
250mg95%$715.00InquiryInquiry
1g95%$1345.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2,6-dioxopiperidin-3-yl)-5-((9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)amino)isoindoline-1,3-dione
IUPAC Name2-(2,6-dioxopiperidin-3-yl)-5-((9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)amino)isoindoline-1,3-dione
Molecular FormulaC23H21N7O5
Molecular Weight475.46
SMILESO=C1CCC(N2C(=O)C3=CC=C(NC4=NC=NC5=C4N=CN5C4CCCCO4)C=C3C2=O)C(=O)N1
InChI KeyRDUKOMAOUNOBAD-UHFFFAOYSA-N

Synthetic Route by SureRoute

1. ACJHIV616 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACALQJ739 route compound structure diagram
    ACALQJ7397306-68-5In Stock
  2. Plus
  3. ACHUST306 route compound structure diagram
    ACHUST306191732-76-0In Stock
  4. Then
  5. ACJHIV616 route product structure diagram
    ACJHIV616-
Inquiry

2. ACJHIV616 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMCAO047 route compound structure diagram
    ACMCAO0477306-67-4In Stock
  2. Plus
  3. ACNYZE284 route compound structure diagram
    ACNYZE28426166-92-7In Stock
  4. Then
  5. ACJHIV616 route product structure diagram
    ACJHIV616-
Inquiry

3. ACJHIV616 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJHIV616 route product structure diagram
    ACJHIV616-
Inquiry

Comments (0)